While EGFR mutations in non-small cell lung cancer were by far the most common and statistically significant in this population (n = 1630), we also found significant associations with small cell lung cancer, prostate cancer, kidney cancer, thyroid cancer, and the heterogeneous group of unknown primary cancers. This evidence concerns the gene EGFR and small cell lung carcinoma.